Roche lung-cancer drug candidate beats existing therapies in late-stage trial, WSJ reports. The experimental treatment outperformed current options in the study.
Roche's lung-cancer drug candidate beat existing therapies in a late-stage clinical trial, according to the Wall Street Journal.
Quick reaction
One tap helps tune what we surface next.
Reader discussion
Public commentsNo comments yet. Start the discussion around this signal.
Follow this signal
Get updates on this story
We will email you if this changes materially. No spam. Daily brief optional.
Map context
See this on the live map
Keep the story in context with nearby live signals, countries, and category movement.
Related coverage
Hubs
Briefings
More story pages
US FDA approves Vertex gene therapy for sickle cell disease in children as young as two, expanding treatment options for the inherited blood disorder.
The US FDA has approved Vertex's gene therapy for sickle cell disease in children as young as two.
WHO declares Ebola outbreak in DR Congo and Uganda an international public health emergency as cases surpass 1,400 with 350 deaths. UN warns crisis could push 1 million people in DR Congo deeper into poverty. Congo
Ebola outbreak in DR Congo and Uganda surpasses 1,400 cases, with 350 deaths and 500 people under isolation. WHO declares the outbreak an international public health emergency as the UN warns the crisis could push 1 million people in DR Congo deeper into poverty.
More live signals
Continue with the live feed.
The fastest nearby updates load from the public feed, not the enriched story endpoint.